CLINIBORG
About
Categories
Privacy Policy
Terms
Acute Bacterial Rhinosinusitis Decision Tool
Dec 21, 2024
•
Mark Morgan
categories:
otolaryngology
This is a diagnostic decision tool.
Acute Bacterial Rhinosinusitis Decision Tool
Risk Factors:
no
YES
<-- Signs and symptoms persistent and no improving for 10+ days
no
YES
<-- Severe for 3+ days
no
YES
<-- Worsening or double-sickening 3+ days
no
YES
<-- Risk for resistance (age 65 years, antibiotic use within the past month, prior hospitalization longer than 5 days, comorbidities, or immunocompromised status)
result
score=(Q1)+(Q2)+(Q3)+(Q4);score>10?'Symptomatic management AND Second-line antimicrobial therapy':score>1?'Symptomatic management AND First-line antimicrobial therapy':'Symptomatic management'
First-line antimicrobial therapy: regular dose amoxicillin/clavulanate. Second-line antimicrobial therapy: high dose amoxicillin/clavulanate; levofloxacin; moxifloxacin (adult); clindamycin AND cefpodoxime OR cefixime; or doxycycline (adult)
display/hide references
reference:
#1
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM Jr, Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr;54(8):e72-e112.
Calculate The Result!
Reset Form
Result - Copy and paste this output:
Copy to Clipboard
Please enable JavaScript to view the
comments powered by Disqus.